Not sure where you actually read that these are known potential side effects of Pulmozyme use. The studies with Pulmozyme and the concerns you mentioned can likely relate to normal progression of the disease itself - NOT necessarily from Pulmozyme use. Take into consideration that an individual with cystic fibrosis is prone to any of these events - with or without the use of Pulmozyme. I tend to go with the conclusion that the effects you've listed don't relate directly to Pulmozyme. Please see <a target=_blank class=ftalternatingbarlinklarge href="http://www.pulmozyme.com/info/prescribing.jsp
">http://www.pulmozyme.com/info/prescribing.jsp
</a>
"Mortality rates observed in controlled trials were similar for the placebo and Pulmozyme treated patients. Causes of death were consistent with progression of cystic fibrosis and included apnea, cardiac arrest, cardiopulmonary arrest, cor pulmonale, heart failure, massive hemoptysis, pneumonia, pneumothorax, and respiratory failure."
Also consider that Pulmozyme doesn't function systemically to thin mucus...thus, the great appeal of other inhaled meds such as TOBI and AZLI. Consider the renal side effects of IV tobramycin vs. inhaled TOBI. The side effects are lessened and pseudomonas is treated directly.